ID NUMBER: CONTACT YEAR: FORM CODE: C E L VERSION G, DATE: 09/28/2015

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

ANNUAL FOLLOW-UP QUESTIONNAIRE FORM

O.M.B 0925-0281 Exp. 05312010 ARIC AUAL FOLLOW-UP QUESTIOAIRE FORM Atherosclerosis Risk in Communities ID UMBER: COTACT EAR: FORM CODE: A F U VERSIO: L DATE:060307 LAST AME: IITIALS: Public reporting burden

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ID NUMBER: FORM NAME: H F A DATE: 10/01/2015 VERSION: D CONTACT YEAR NUMBER: FORM SEQUENCE NUMBER: General Instructions: The Heart Failure Hospital Record

C O R EVENT ID: FORM CODE: VERSION: C DATE: 04/01/10

O. M. B. 0925-0281 Exp. 04/30/2013 ARIC Atherosclerosis Risk in Communities COROER / MEDICAL EXAMIER FORM C O R EVET ID: FORM CODE: VERSIO: C DATE: 04/01/10 LAST AME: IITIALS: Public reporting burden for

QUESTION-BY-QUESTION INSTRUCTIONS FOR MMCC HEART FAILURE FINAL DIAGNOSIS FORM (HDX)

QUESTION-BY-QUESTION INSTRUCTIONS FOR MMCC HEART FAILURE FINAL DIAGNOSIS FORM (HDX) HDX, Version A, 09-10-2009 HDX QxQ An MMCC Heart Failure Diagnosis Form (HDX) is completed for each ARIC Heart Failure

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

DUKECATHR Dataset Dictionary

DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of

Form 136 WHI WOMEN S HEALTH INITIATIVE HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

Form 136 WHI WOMEN S HEALTH INITIATIVE HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM FORM NAME: H T F DATE: 10/31/2012 VERSION: A MEMBER ID NUMBER: General Instructions: This form should be completed

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for

Manual 3c. Stroke Cohort Surveillance Procedures Manual of Operations

ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY Manual 3c Stroke Cohort Surveillance Procedures Manual of Operations Version 1 8/31/2018 Sponsored by: http://www.nhlbi.nih.gov/ National Heart, Lung, and Blood

ARIC Data Book. CHD Cohort Surveillance

Page 1 of 14 Coroner/Medical Examiner Form Data set name: C17CORA1 Instructions: The Coroner/Medical Examiner Form is completed for each eligible out-of-hospital death that was identified as a coroner

February 25, WHI Heart Failure Data Summary. A. Original WHI outcome (referred to as CHF)

February 25, 2014 WHI Heart Failure Data Summary A. Original WHI outcome (referred to as CHF) Process: Sample: Collected and centrally adjudicated for HT participants and locally adjudicated on all non-ht

ARIC. HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM with SUPPLEMENTAL INFORMATION

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM with SUPPLEMENTAL INFORMATION ID NUMBER: FORM NAME: H F S DATE: 06/28/2012 VERSION: B Note: This form will only be done on a subset of participants.

Lnformation Coverage Guidance

Lnformation Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity Abstract: B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It

Acute Coronary Syndrome

ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

Multi-Ethnic Study of Atherosclerosis Participant ID: Hospital Code: Hospital Abstraction: Stroke/TIA History and Hospital Record 1. Was the participant hospitalized as an immediate consequence of this

PERFORMANCE MEASURE TECHNICAL SPECIFICATIONS. HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate

PERFORMANCE MEASURE TECHNICAL SPECIFICATIONS HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate Measure Title Description Measure Type Data Source Level of Analysis Numerator HRS-3:

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart

Chapter 9: Cardiovascular Disease in Patients With ESRD

Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in adult ESRD patients, with atherosclerotic heart disease and congestive heart failure being the most common conditions

(For items 1-12, each question specifies mark one or mark all that apply.)

Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

Supplement Table 1. Definitions for Causes of Death

Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX

10. Definition of cardiovascular disease 10.1 Nosologic definitions Acute myocardial infarction: myocardial cell death due to prolonged ischaemia 62.

10. Definition of cardiovascular disease 10.1 Nosologic definitions Acute myocardial infarction: myocardial cell death due to prolonged ischaemia 62. Acute coronary syndrome: it is a big category which

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD The prevalence of cardiovascular disease is 68.8% among patients aged 66 and older who have CKD, compared to 34.1% among those who do not have CKD

Cardiovascular Disease

Cardiovascular Disease Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars on the 3 rd Wednesday of each month to address topics related to risk adjustment

CARDIA Endpoint Events Manual of Operations

CARDIA Endpoint Events Manual of Operations CARDIA Endpoint Events Manual of Operations v09/12/2012 Table of Contents Page 1. Introduction... 1 2. Organization and Goals of the Endpoints Surveillance and

WHI - Volume 8, Section 5 - Outcome Classifications: Cardiovascular Outcomes Page 5-1 SECTION 5 OUTCOME CLASSIFICATIONS: CARDIOVASCULAR OUTCOMES

WHI - Volume 8, Section 5 - Outcome Classifications: Cardiovascular Outcomes Page 5-1 SECTION 5 OUTCOME CLASSIFICATIONS: CARDIOVASCULAR OUTCOMES INTRODUCTION Specific cardiovascular diseases (CVDs) are

TEXAS - MAC - PART B - TRAILBLAZER RADIOLOGY TABLE OF CONTENTS

RADIOLOGY TABLE OF CONTENTS CPT to LCD ID CodeMap Mappings... 3 - Automatic Implantable Cardiac Defibrillator (AICD) - 4C-58AB-R1 11 L26529- Cardiac Catheterization - 4C-50AB-R3... 20 L26534- Transthoracic

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Surgery and device intervention for the elderly with heart failure: assessing the need Devices and Technology for heart failure in 2011 Assessing cardiovascular function / prognosis (in the elderly): composite

Difficult Data Definitions and Scenario s

Difficult Data Definitions and Scenario s Presenter Disclosure Information Cornelia Anderson BSN, RN To following relationships exist related to this presentation: No Disclosures Objectives Discuss key

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

ANNUAL FOLLOW-UP FORM

Public reporting burden for this collection of information is estimated to average 6-15 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)

2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the

<INSERT COUNTRY/SITE NAME> All Stroke Events

WHO STEPS STROKE INSTRUMENT For further guidance on All Stroke Events, see Section 5, page 5-15 All Stroke Events Patient Identification and Patient Characteristics (I 1) Stroke

SCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA

Journal Club 19 Marzo 2010 SCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA Alessandro Giordano Prevalence of heart failure by sex and age (NHANES:1999-2004) Circulation 2007 Incidence of heart failure by age

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION The Asymptomatic Myocardial Ischemia in Stroke and Atherosclerotic Disease

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions The Clinical Revisions provide details of changes to InterQual Clinical Criteria. They do not provide information on changes made to CareEnhance

The Counter HF Clinical Study for Heart Failure

The Counter HF Clinical Study for Heart Failure CAUTION: C-Pulse is an investigational device. It is limited by Federal (or United States) Law to investigational use only. 13-111-B Agenda Heart Failure

ARIC Surveillance Variable Dictionary. Incident Stroke

ARIC Surveillance Variable Dictionary Incident Stroke April 2002 j:\aric\admin\vardict\stroke_inc ARIC Surveillance Variable Dictionary Incident a Stroke Table of Contents for Year YY b Alphabetical Index...ii

CARDIOVASCULAR DISEASE EVENT CLASSIFICATION IN THE JACKSON HEART STUDY: METHODS AND PROCEDURES

CARDIOVASCULAR DISEASE EVENT CLASSIFICATION IN THE JACKSON HEART STUDY: METHODS AND PROCEDURES Objective: The process of identifying, abstracting, and classifying cardiovascular disease (CVD) endpoints

Detailed Order Request Checklists for Cardiology

Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

EHMRG SCORE STUDY version 6.2; date: 11Jul11 PI: Dr. Douglas Lee. Study Background

EHMRG SCORE STUDY version 6.2; date: 11Jul11 PI: Dr. Douglas Lee Study Background Heart failure (HF) is a leading cause of morbidity and cardiovascular mortality. The burden of HF has increased over time

Chapter 8: Cardiovascular Disease in Patients with ESRD

Chapter 8: Cardiovascular Disease in Patients with ESRD Cardiovascular disease (CVD) is common in adult end-stage renal disease (ESRD) patients, with coronary artery disease (CAD) and heart failure (HF)

Stable Angina: Indication for revascularization and best medical therapy

Stable Angina: Indication for revascularization and best medical therapy Cardiology Basics and Updated Guideline 2018 Chang-Hwan Yoon, MD/PhD Cardiovascular Center, Department of Internal Medicine Bundang

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk

CAPTIVATE SUMMARY CLINICAL SUMMARY. CAPTure Information Via Automatic Threshold Evaluation

CLINICAL SUMMARY CAPTIVATE SUMMARY CAPTure Information Via Automatic Threshold Evaluation CAUTION: Federal law restricts this device to sale by or on the order of a physician trained or experienced in

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

A. ADMINISTRATIVE New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) 1. Facility Code: 2. Facility Name: 3. Procedure Type (Choose only

THE NATIONAL QUALITY FORUM

THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use

Consensus Core Set: Cardiovascular Measures Version 1.0

Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized

4. Which survey program does your facility use to get your program designated by the state?

STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

ALLHAT. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute

U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute Review of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment

Management Strategies for Advanced Heart Failure

Management Strategies for Advanced Heart Failure Mary Norine Walsh, MD, FACC Medical Director, HF and Cardiac Transplantation St Vincent Heart Indianapolis, IN USA President American College of Cardiology

The Muscatine Study Heart Health Survey

The Muscatine Study Heart Health Survey PARTICIPANT ID LABEL (include study ID, name, DOB, gender) Today s Date: - - (MM-DD-YYYY) Thank you for agreeing to participate in the International Childhood Cardiovascular

Supplementary Online Content

Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

Medicare and Medicaid Payments

and Payments The following table includes information about payments made by and for the 17 medical conditions/surgical procedures included in this Hospital Performance Report. This analysis is based on

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card

2014: Reference Mapping Card 162.3 Malignant neoplasm upper lobe lung 162.5 Malignant neoplasm lower lobe lung 162.9 lung/bronchus 396.2 396.3 Mitral insufficiency, aortic stenosis Mitral aortic valve

Assessment and Diagnosis of Heart Failure

Assessment and Diagnosis of Heart Failure Heart failure (HF) is a complex clinical syndrome resulting from any structural or functional impairment of ventricular filling or ejection of blood and is characterized

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL Table S1. Patient Selection Codes, CIED Generator Procedures Code Type Code Description ICD9 Proc 00.51 Implantation of cardiac resynchronization defibrillator, total system [CRT-D]

Supplementary webappendix

Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ray K K, Seshasai S R K, Wijesuriya S,

Heart Failure Clinician Guide JANUARY 2016

Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

Supplemental Material

Supplemental Material 1 Table S1. Codes for Patient Selection Cohort Codes Primary PM CPT: 33206 or 33207 or 33208 (without 33225) ICD-9 proc: 37.81, 37.82, 37.83 Primary ICD Replacement PM Replacement

Chapter 4: Cardiovascular Disease in Patients with CKD

Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%

Process Measure: Screening for Adult Obstructive Sleep Apnea

Process Measure: Screening for Adult Obstructive Sleep Apnea Measure Description Description Type of Measure All patients aged 18 years and older at high risk for obstructive sleep apnea (OSA) with documentation

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

EACTS Adult Cardiac Database

EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

National Imaging Associates, Inc. Clinical guidelines CARDIOVASCULAR NUCLEAR MEDICINE -MYOCARDIAL PERFUSION IMAGING -MUGA Original Date: October 2015 Page 1 of 9 FOR CMS (MEDICARE) MEMBERS ONLY CPT4 Codes:

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center March 2014 Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading

The American Experience

The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

Cohort Surveillance Heart Failure Occurrences Data Dictionary

Atherosclerosis Risk in Communities Study Cohort Surveillance Heart Failure s Data Dictionary September 2017 Cohort Surveillance Heart Failure s Data Dictionary : An occurrence refers to a single hospitalization,

Coronary Interventions Indications, Treatment Options and Outcomes

Coronary Interventions Indications, Treatment Options and Outcomes A talk should be like a woman s skirt long enough to cover the subject, but short enough to keep it interesting. Coronary anatomy Physiology

Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Spending

1 Funding from the National Institute on Aging (T32-AG000186 to the National Bureau of Economic Research and P01-AG019783 to Dartmouth) and LEAP at Harvard University. Survey data collected under P01-AG019783

APPENDIX F: CASE REPORT FORM

APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more

Can be felt where an artery passes near the skin surface and over a

1 Chapter 14 Cardiovascular Emergencies 2 Cardiovascular Emergencies Cardiovascular disease has been leading killer of Americans since. Accounts for 1 of every 2.8 deaths Cardiovascular disease (CVD) claimed

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

(auto) à If Yes, Most Recent LVEF Date 4155 : à If Yes, Most Recent LVEF 4160 :

A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : Sex 2060 : O Male O Female Patient Zip Code

Chapter 14. Cardiovascular Emergencies

Chapter 14 Cardiovascular Emergencies Introduction (1 of 2) Cardiovascular disease has been leading killer of Americans since 1900. Accounts for 1 of every 2.8 deaths Introduction (2 of 2) EMS can help

Appendix 1: Supplementary tables [posted as supplied by author]

Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial

Is it HF secondary to rheumatic heart disease???

Is it HF secondary to rheumatic heart disease??? Is mitral regurg. Is complication of CHF??? Cardiomyopathy Definition The term cardiomyopathy is purely descriptive, meaning disease of the heart muscle

Ischaemic cardiovascular disease

Ischaemic cardiovascular disease What are the PHO performance programme indicators and how are they best achieved? 40 BPJ Issue 36 Supporting the PHO Performance Programme The PHO Performance Programme

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.

SUPPLEMENTAL MATERIAL Supplemental Table 1. Standardized Serum Creatinine Measurements Supplemental Table 2. List of ICD 9 and ICD 10 Billing Codes Supplemental Table 3. Sensitivity Analyses with Additional

Chapter 14 Cardiovascular Emergencies Cardiovascular Emergencies Cardiovascular disease has been leading killer of Americans since.

1 2 3 4 5 Chapter 14 Cardiovascular Emergencies Cardiovascular Emergencies Cardiovascular disease has been leading killer of Americans since. Accounts for 1 of every 2.8 deaths Cardiovascular disease (CVD)

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

CLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical

Rhythm Disorders 2017 TazKai LLC and NRSNG.com

Rhythm Disorders 1. Outline the conduction system of the heart. 2. What do the different portions of the EKG represent? 3. Define the following terms: a. Automaticity b. Conductivity c. Excitability d.

INSTRUCTIONS FOR THE SEMI-ANNUAL FOLLOW-UP CORE QUESTIONS (4/30/2018) (SAF, VERSION 3, 4/30/2018)

INSTRUCTIONS FOR THE SEMI-ANNUAL FOLLOW-UP CORE QUESTIONS (4/30/2018) (SAF, VERSION 3, 4/30/2018) I. General Instructions Semi-annual follow-up of the ARIC Study cohort is used to maintain contact and

Chapter 4 Section 9.1

Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

Οξύ στεφανιαίο σύνδρομο και καρδιογενής καταπληξία. Επεμβατική προσέγγιση. Σωτήριος Πατσιλινάκος Κωνσταντοπούλειο Γ.Ν. Ν. Ιωνίας

Οξύ στεφανιαίο σύνδρομο και καρδιογενής καταπληξία. Επεμβατική προσέγγιση Σωτήριος Πατσιλινάκος Κωνσταντοπούλειο Γ.Ν. Ν. Ιωνίας ACUTE HEART FAILURE AND CAD: ACS / LV ischaemic dysfunction Mechanical complications

Chapter 4 Section 9.1

Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33200-37186, 37195-37785, 92950-93272, 93303-93581,